|
Market Closed -
Australian S.E.
07:10:28 28/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 181.91 AUD | +2.80% |
|
+2.02% | +5.36% |
| 09-22 | Csl Canada Expands Public Access to Andembry® Across Canada for the Prevention of Hereditary Angioedema Attacks | CI |
| 09-21 | Australian shares end flat as miners offset gains in banks | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CSL LIMITED | Biopharmaceuticals | +2.80% | +2.02% | +5.36% | -8.59% | -38.22% | 59.52B |  | |  |
- Stock Market
- Stocks
- CSL Stock
- Charts CSL Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
